Related Experiment Video

Updated: Dec 29, 2025

Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

8.0K

Recent Updates on Mesenchymal Stem Cell Based Therapy for Acute Renal Failure

Asmaa Missoum1

  • 1Department of Biological and Environmental Sciences, Qatar University, Doha, Qatar.

Current Urology
|January 31, 2020
PubMed

Insights

Mesenchymal stem cells (MSCs) show promise in treating acute kidney injury by reducing renal failure through paracrine and immunomodulatory effects. Different MSC sources offer unique therapeutic potential but require further research regarding clinical application challenges.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Acute kidney injury (AKI) involves loss of renal proximal tubule epithelial cells due to ischemia or toxic damage.
  • Pathophysiology includes oxidative stress, mitochondrial dysfunction, and direct tubular cell toxicity, leading to severe renal function decline.
  • Current treatments for AKI are invasive and costly, such as dialysis and organ transplantation.

Purpose of the Study:

  • To review and compare the efficacy of different mesenchymal stem cell (MSC) sources for treating renal failure.
  • To highlight the paracrine and immunomodulatory mechanisms by which MSCs ameliorate kidney injury.
  • To discuss future clinical application challenges of MSCs in AKI treatment.

Main Methods:

  • Review of recent research studies on MSCs for renal failure.
  • Comparison of therapeutic capacities, advantages, and drawbacks of various MSC sources.
  • Analysis of concerns regarding MSC homing, toxicity, and immune rejection.

Main Results:

  • Mesenchymal stem cells (MSCs) demonstrate effectiveness in ameliorating renal failure.
  • Therapeutic outcomes vary depending on the source of MSCs (e.g., dental pulp, umbilical cord, bone marrow).
  • MSCs exert therapeutic effects through paracrine and immunomodulatory mechanisms.

Conclusions:

  • MSCs offer a promising therapeutic avenue for acute kidney injury.
  • The choice of MSC source impacts therapeutic potential and clinical applicability.
  • Further research is needed to address challenges like homing, toxicity, and immune rejection for successful clinical translation.
Keywords:
Acute kidney injuryAcute renal failureCisplatinGlomerular filtration rateIschemia/reperfusion injuryMesenchymal stem cells

More Related Videos

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells09:05

A Novel Clinical Grade Isolation Method for Human Kidney Perivascular Stromal Cells

Published on: August 7, 2017

7.2K
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

17.8K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
774
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
635
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
232